Customization: | Available |
---|---|
Transport Package: | Carton |
Specification: | injection |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Name | Potassium sodium pehydroandroandrographolide succinate for injection |
Main Ingredients | Inflammation Hu ning |
Adaptation disease | It is suitable for viral pneumonia and upper respiratory tract infection |
Character | This product is white or yellowish powder or lump |
Dosage | Powder-injection |
Specification | (1)40mg; (2)80mg; (3)0.16g; (4)0.2g; (5)0.4g. |
Directions | Dissolve with appropriate amount of sterilized water for injection before use. Intramuscular injection: 40 ~ 80mg once, once or twice a day; Intravenous infusion: 5% glucose injection or 5% glucose sodium chloride injection was dissolved and diluted, then intravenous infusion was given 0.16 ~ 0.4g a day, once or twice a day. Reduce your child's weight or follow doctor's advice |
Storage | Airtight, store in a cool and dry place (not more than 20ºC) |
Validity | 24 month |
Origin | China |
Notice | [Adverse reactions] There are few literature reports on the clinical application of yanhuning, and allergic reactions such as rash are occasionally seen. In animal experiments, muscle administration showed a local stimulus response. The active metabolites of yanhuning and chuanhuning in vivo are the same substance. The adverse reactions observed after the marketing of Chuanhuning are reported in literature: 1. Allergic reactions can be manifested as rash, pruritus, macules, severe even dyspnea, edema, anaphylactic shock, mostly in the first use of drugs; 2. Digestive tract reaction nausea, vomiting, abdominal pain, diarrhea, also reported liver function damage; 3. Blood system reaction can see leukopenia, thrombocytopenia, purpura, etc. 4. The original samples caused by heat reflect chills, high fever, even dizziness, chest tightness, palpitations, tachycardia, decreased blood pressure, etc. [Contraindication] 1. This product is contraindicated in allergic people. 2. It is forbidden for pregnant women. 1. In case of fever or shortness of breath during use, the drug should be stopped immediately. In the event of anaphylactic shock, take appropriate first aid measures immediately. 2. This product should be prepared fresh before infusion, and prohibited when drug properties change. [Pregnant women and lactating women] This product has cytotoxic effect on placental villus trophoblast cells, animal tests suggest that it has anti-early and middle pregnancy effect, so pregnant women are prohibited. (Medication for children ) Children should reduce their medication according to doctor's advice. ( Medication for the elderly ) Use with caution or as advised by the doctor. 1. This product should not be compatible with acid, alkaline drugs or drugs containing sodium bisulfite, sodium metabisulfite as antioxidant. 2. This product is not compatible with aminoglycoside and quinolone drugs. |